Search

Your search keyword '"Minoru Ichikawa, MD, PhD"' showing total 1 results
Start Over Author "Minoru Ichikawa, MD, PhD" Search Limiters Full Text
1 results on '"Minoru Ichikawa, MD, PhD"'

1. Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation

Author

Yoshizumi Takei, MD, Minoru Ichikawa, MD, PhD, and Yoshiyuki Kijima, MD, PhD

Subjects
Atrial fibrillation, Free radicals, Matrix metalloproteinase, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

We aimed to determine the effects of the oral direct renin inhibitor aliskiren on in vivo oxidative stress in atrial fibrillation (AF) patients. In this study, 150 mg oral direct renin inhibitor aliskiren was administered once daily to 12 permanent AF patients. Aliskiren significantly reduced urinary excretion of the oxidative stress biomarker 8-iso-prostglandin F2α and serum levels of matrix metalloproteinase-2(MMP-2). We concluded that aliskiren reduces in vivo oxidative stress and serum MMP-2 levels in patients with permanent AF.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results